Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cutler

Showing results (511-520 of 543) with videos related to

Pageof 55
Sort By:
Blood|November 8, 2019
Inhibition of inositol kinase B controls acute and chronic graft-versus-host diseaseGovindarajan Thangavelu, Jing Du, Katelyn G Paz, et al.
JCI Insight|June 15, 2017
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibitionEdouard Forcade, Katelyn Paz, Ryan Flynn, et al.
Blood Advances|December 5, 2025
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor risk MDS/AMLJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Blood|March 18, 2016
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanismRyan Flynn, Katelyn Paz, Jing Du, et al.
Blood|April 16, 2011
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysisMukta Arora, John P Klein, Daniel J Weisdorf, et al.
Blood|September 1, 2011
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseDavid A Jacobsohn, Mukta Arora, John P Klein, et al.
The New England Journal of Medicine|October 19, 2012
Peripheral-blood stem cells versus bone marrow from unrelated donorsClaudio Anasetti, Brent R Logan, Stephanie J Lee, et al.
The Journal of Clinical Investigation|June 10, 2020
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host diseaseSherrie J Divito, Anders T Aasebø, Tiago R Matos, et al.
Transplantation and Cellular Therapy|June 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD ReportZachariah DeFilipp, Daniel R Couriel, Aleksandr Lazaryan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2013
Providing personalized prognostic information for adult leukemia survivorsStephanie J Lee, Barry Storer, Hailin Wang, et al.
Pageof 55

Showing results (511-520 of 543) with videos related to

Sort By:
Pageof 55
Blood|November 8, 2019
Inhibition of inositol kinase B controls acute and chronic graft-versus-host diseaseGovindarajan Thangavelu, Jing Du, Katelyn G Paz, et al.
JCI Insight|June 15, 2017
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibitionEdouard Forcade, Katelyn Paz, Ryan Flynn, et al.
Blood Advances|December 5, 2025
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor risk MDS/AMLJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Blood|March 18, 2016
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanismRyan Flynn, Katelyn Paz, Jing Du, et al.
Blood|April 16, 2011
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysisMukta Arora, John P Klein, Daniel J Weisdorf, et al.
Blood|September 1, 2011
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseDavid A Jacobsohn, Mukta Arora, John P Klein, et al.
The New England Journal of Medicine|October 19, 2012
Peripheral-blood stem cells versus bone marrow from unrelated donorsClaudio Anasetti, Brent R Logan, Stephanie J Lee, et al.
The Journal of Clinical Investigation|June 10, 2020
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host diseaseSherrie J Divito, Anders T Aasebø, Tiago R Matos, et al.
Transplantation and Cellular Therapy|June 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD ReportZachariah DeFilipp, Daniel R Couriel, Aleksandr Lazaryan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2013
Providing personalized prognostic information for adult leukemia survivorsStephanie J Lee, Barry Storer, Hailin Wang, et al.
Pageof 55